Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging

Neurobiology of Aging

Volumn 30, Issue 6, 2009, Pages 864-874

  Woodhouse, Adele ^a   Vickers, James C ^a   Adlard, Paul A ^b   Dickson, Tracey C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Alpha internexin; Dystrophic neurites; Hyperphosphorylated tau; Neurofilament; Pathological aging; Preclinical Alzheimer's disease; Tg2576; TgCRND8

Indexed keywords

ALPHA INTERNEXIN; AMYLOID BETA PROTEIN; TAU PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DENDRITE; DYSTROPHY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NEURITE; NEUROCHEMISTRY; NEUROFILAMENT; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; SENILE PLAQUES;

EID: 65249085666     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.09.003     Document Type: Article

References (42)

1. Adlard P.A., and Vickers J.C. Morphologically distinct plaque types differentially affect dendritic structure and organization in the early and late stages of Alzheimer's disease. Acta Neuropathol. 103 (2002) 377-383
2. Akiyama H., Schwab C., Kondo H., Mori H., Kametani F., Ikeda K., and McGeer P.L. Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein. Neurosci. Lett. 206 (1996) 169-172
3. Akiyama H., Hiroshi M., Saido T., Kondo H., Ikeda K., and McGeer P.L. Occurrence of the diffuse amyloid β-protein (Aβ) deposits with numerous Aβ-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia 25 (1999) 324-331
4. Bergamaschini L., Rossi E., Storini C., Pizzimenti S., Distaso M., Perego C., Luigi A., Vergani C., and De Simoni M.G. Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease. J. Neurosci. 24 (2004) 4181-4186
5. Blanchard V., Moussaoui S., Czech C., Touchet N., Bonici B., Planche M., Canton T., Jedidi I., Gohin M., Wirths O., Bayer T.A., Langui D., Duyckaerts C., Tremp G., and Pradier L. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Exp. Neurol. 184 (2003) 247-263
6. Borroni B., Premi E., Di Luca M., and Padovani A. Combined biomarkers for early Alzheimer's disease diagnosis. Curr. Med. Chem. 14 (2007) 1171-1178
7. Boutajangout A., Authelet M., Blanchard V., Touchet N., Tremp G., Pradier L., and Brion J.-P. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1. Neurobiol. Dis. 15 (2004) 47-60
8. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
9. Bussière T., Bard F., Barbour B., Grajeda H., Guido T., Khan K., Schenk D., Games D., Seubert P., and Buttini M. Morphological characterization of thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am. J. Pathol. 165 (2004) 987-995
10. Chishti M.A., Yang D.-S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Carlson G.A., St George-Hyslop P., and Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276 (2001) 21562-21570
11. Czech C., Tremp G., and Pradier L. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog. Neurobiol. 60 (2000) 363-384
12. Delatour B., Blanchard V., Pradier L., and Duyckaerts C. Alzheimer pathology disorganized cortico-cortical circuitry: direct evidence from a transgenic animal model. Neurobiol. Dis. 16 (2004) 41-47
13. De Leon M.J., Mosconi L., Blennow K., DeSanti S., Zinkowski R., Mehta P.D., Pratico D., Tsui W., Saint Louis L.A., Sobanska L., Brys M., Li Y., Rich K., Rinne J., and Rusinek H. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann. N. Y. Acad. Sci. 1097 (2007) 114-145
14. Dickson T.C., King C.E., McCormack G.H., and Vickers J.C. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Exp. Neurol. 156 (1999) 100-110
15. Dickson T.C., Adlard P.A., and Vickers J.C. Sequence of cellular changes following localized axotomy to cortical neurons in glia-free cultures. J. Neurotrauma 17 (2000) 1095-1103
16. Dickson T.C., Chuckowree J.A., Chuah M.I., West A.K., and Vickers J.C. Novel Alzheimer's disease pathology reflects variable neuronal vulnerability and demonstrates the role of b-amyloid plaques in neurodegeneration. Neurobiol. Dis. 18 (2005) 286-295
17. Dudal S., Krzywkowski P., Paquette J., Morissette C., Lacombe D., Tremblay P., and Gervais F. Inflammation occurs early during the Aβ deposition process in TgCRND8 mice. Neurobiol. Aging 25 (2004) 861-871
18. Evans J., Sumners C., Moore J., Huentelman M.J., Deng J., Gelband C.H., and Shaw G. Characterization of mitotic neurons derived from adult rat hypothalamus and brain stem. J. Neurophysiol. 87 (2002) 1076-1085
19. Ferrer I., Rovira M.B., Sanchez Guerra M.L., Rey M.J., and Costa-Jussa F. Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease. Brain Pathol. 14 (2004) 11-20
20. Higgins G.A., and Jacobsen H. Transgenic mouse models of Alzheimer's disease: phenotype and application. Behav. Pharmacol. 14 (2003) 419-428
21. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
22. Knowles R.B., Gomez-Isla T., and Hyman B.T. Aβ associated neuropil changes: correlation with neuronal loss and dementia. J. Neuropathol. Exp. Neurol. 57 (1998) 1122-1130
23. Kurt M.A., Davies D.C., Kidd M., Duff K., and Howlett D.R. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Neurobiol. Dis. 14 (2003) 89-97
24. Le R.L., Cruz L., Urganc B., Knowles R.B., Hsiao-Ashe K., Duff K., Irizarry M.C., Stanley H.E., and Hyman B.T. Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption. J. Neuropathol. Exp. Neurol. 60 (2001) 753-758
25. Masliah E., Mallory M., Hansen L., Alford M., DeTeresa R., and Terry R. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am. J. Pathol. 142 (1993) 871-881
26. Masliah E., Sisk A., Mallory M., and Games D. Neurofibrillary pathology in transgenic mice overexpressing V717F β-amyloid precursor protein. J. Neuropathol. Exp. Neurol. 60 (2001) 357-368
27. Matsunaga W., Miyata S., Hashimoto Y., Lin S.H., Nakashima T., Kiyohara T., and Matsumoto T. Microtubule-associated protein-2 in the hypothalamo-neurohypophysial system: low-molecular-weight microtubule-associated protein-2 in pituitary astrocytes. Neuroscience 88 (1999) 1289-1297
28. McLaurin J., Kierstead M.E., Brown M.E., Hawkes C.A., Lambermon M.H.L., Phinney A.L., Darabie A.A., Cousins J.E., French J.E., Lan M.F., Chen F., Wong S.S.N., Mount H.T.J., Fraser P.E., Westaway D., and St George-Hyslop P. Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat. Med. 12 (2006) 801-808
29. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Brownlee L.M., Vogel F.S., van Belle G., and Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
30. Nicoll J.A.R., Wilkinson D., Holmes C., Steart P., Markham H., and Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med. 9 (2003) 448-452
31. Noda-Saita K., Terai K., Iwai A., Tsukamoto M., Shitaka Y., Kawabata S., Okada M., and Yamaguchi T. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease. Acta Neuropathol. 108 (2004) 435-442
32. Oddo S., Billings L., Kesslak J.P., Cribbs D.H., and LaFerla F.M. Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43 (2004) 321-332
33. Orgogozo J.-M., Gilman S., Dartigues J.-F., Laurent B., Puel M., Kirby L.C., Jouanny P., Dubois B., Eisner L., Flitman S., Michel B.F., Boada M., Frank A., and Hock C. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology 61 (2003) 46-54
34. Porzig R., Singer D., and Hoffmann R. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem. Biophys. Res. Commun. 358 (2007) 644-649
35. Price J.L., and Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 45 (1999) 358-368
36. Savage M.J., Iqbal M., Loh T., Trusko S.P., Scott R., and Siman R. Cathespin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience 60 (1994) 607-619
37. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., and Seubert P. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 400
38. Schwab C., Hosokawa M., and McGeer P.L. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp. Neurol. 188 (2004) 52-64
39. Su J.H., Cummings B.J., and Cotman C.W. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res. 739 (1996) 79-87
40. Su J.H., Cummings B.J., and Cotman C.W. Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites. Acta Neuropathol. 96 (1998) 463-471
41. Vickers J.C., Dickson T.C., Adlard P.A., Saunders H.L., King C.E., and McCormack G. The cause of neuronal degeneration in Alzheimer's disease. Prog. Neurobiol. 60 (2000) 139-165
42. Woodhouse A., West A.K., Chuckowree J.A., Vickers J.C., and Dickson T.C. Does β-amyloid plaque formation cause structural injury to neuronal processes?. Neurotox. Res. 7 (2005) 5-15